USPTO 2015–2025 USPTO PatentsView US Corporation

Nimbus Lakshmi, Inc.

USPTO PatentsView assignee record - 25 granted patents across 6 technology areas, recorded in grant years 2016–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

RSS updates for this company

The verdict

According to USPTO PatentsView, Nimbus ranks #12,138 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 6 technology areas.

#12,138
of 49,997 US assignees by volume
39th percentile
by Innovation Score (31.9/100)
17.5
avg claims per patent
+113%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12138 · US Corporation #12,138 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 25 grants
  • UPPER-Q #12,138/49,997
  • PHOTO-FINISH National Coupling
  • CPC-NARROW C07D · 6 areas
  • INNOV-THIN 31.9/100
  • CLAIMS-RICH 17.5 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +113% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: National Coupling Company, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Nimbus’s 31.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Nimbus

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Nimbus's Innovation Score is 31.9/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Nimbus?

Each dot is one of Nimbus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nimbus’s own 17.5 claims/patent is ABOVE the 16.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Nimbus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 24.924.92525.1 0204060 Granted patents (volume) Avg claims / patent NP Medical Inc. - 25, 20.4NP MedicalNuevolution A/S - 25, 51.52Nuevolution A/SNational Coupling Company, Inc. - 25, 16.68National CouplingNaver Business Platform Corporation - 25, 15.44Naver Business Pl…NoNO Inc. - 25, 16NonoNora Lighting, Inc. - 25, 2.44Nora LightingNorma U.S. Holding LLC - 25, 13.88Norma U S HoldingNuvaira, Inc. - 25, 19.4NuvairaNimbus Lakshmi, Inc. - 25, 17.48Nimbus Lakshmi
Nimbus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Nimbus's grants concentrate

Nimbus Lakshmi, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 96% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2020 (7 grants) versus a trough of 1 in 2016. By volume, Nimbus sits between NP Medical Inc. and Nuvaira, Inc..

Nimbus's three-year grant acceleration

Nimbus Lakshmi, Inc. shows 4 grants in 2022–2024 against only 18 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Nimbus's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Nimbus holds 25 patents at rank #12,139, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Nimbus

By rank, the assignees closest to #12,139 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Nimbus's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Nimbus, neither rank-band nor same-CPC leaders (those blocks stay above). In C07D (Heterocyclic Compounds), Nimbus ranks #357 of 3,165 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (32 here).

Nimbus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 2016201720182019202020212022 4
USPTO utility patent grants by year · 2016–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Nimbus Lakshmi, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 1 4.0%
2017 1 4.0%
2018 1 4.0%
2019 5 20.0%
2020 7 28.0%
2021 6 24.0%
2022 4 16.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Nimbus Lakshmi, Inc.'s patent record in context - here's where to go next.

  • Nimbus Lakshmi, Inc.'s lead technology class is C07D (Heterocyclic Compounds), 96% of its portfolio - see every assignee active in that class. Explore C07D
  • Ranked #12,138 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Nimbus Lakshmi, Inc. against NP Medical Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 31.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.